DeltaPatents has expanded its Basic IP course offering. New course dates have been planned for Q4 2011 and Q1 2012. The Basic IP courses are particularly useful for those directly or indirectly involved in innovation, such as research scientists, development engineers, inventors, entrepeneurs, project leaders, group leaders, IP coordinators and R&D managers. However, patent attorney trainees who are new to the profession may benefit from these courses as well.
Read more...
DeltaPatents
DeltaPatents is a patent attorney firm based in the Netherlands with a passion for quality. The firm was founded in 2001 in Eindhoven, one of Europe’s leading technology cities.
We provide the highest quality advice and service to public and private companies at various stages of growth from start-up to Fortune 500.
All of our patent specialists have a deep technological knowledge and extensive industrial experience at companies such as Philips, NXP, Zeneca and Shell.
We are also proud to be a leading training organization for the European Qualifying Examination, required to represent clients before the EPO. Through our education activities, we stay ahead in terms of law changes, case law and procedural requirements.
This in-depth industrial experience and up-to-date legal knowledge contributes to a true expertise in patent drafting and defending interests in examination, opposition and appeal proceedings, under both the European Patent Convention (EPC) and Patent Cooperation Treaty (PCT).
In addition to our training programs, we provide a range of high quality seminars in the fields of intellectual property developments, protection and exploitation.
"The future belongs to those who can see opportunities before they get obvious"
(Oscar Wilde)

DeltaPatents nodigt u uit om haar stand te bezoeken op de Regio Business Dagen Zuid-Oost Brabant die in Eindhoven op 13 en 14 september plaats zullen vinden in Beursgebouw Eindhoven. We zien er naar uit om u persoonlijk te ontmoeten bij onze stand.
The results of the EQE 2011 have been published by the EPO. For an initial analysis of the results, see